Intuitive Surgical, Inc. (NASDAQ:ISRG) VP Sells $464,761.80 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) VP Fredrik Widman sold 810 shares of the stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $464,761.80. Following the sale, the vice president now directly owns 473 shares in the company, valued at $271,397.94. This trade represents a 63.13 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Intuitive Surgical Stock Up 1.8 %

Shares of ISRG opened at $568.02 on Thursday. The stock has a fifty day simple moving average of $571.70 and a two-hundred day simple moving average of $530.90. The company has a market capitalization of $202.32 billion, a PE ratio of 88.61, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00.

Analyst Ratings Changes

A number of research analysts have weighed in on ISRG shares. Jefferies Financial Group upped their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. JPMorgan Chase & Co. increased their price target on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Stifel Nicolaus raised their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, December 5th. UBS Group upped their target price on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. Finally, Citigroup lifted their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Institutional Investors Weigh In On Intuitive Surgical

Several hedge funds and other institutional investors have recently bought and sold shares of ISRG. Atala Financial Inc acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $25,000. Hurley Capital LLC acquired a new stake in Intuitive Surgical during the fourth quarter worth $28,000. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical in the fourth quarter valued at $26,000. Parvin Asset Management LLC purchased a new position in shares of Intuitive Surgical during the 4th quarter worth $26,000. Finally, BankPlus Trust Department acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth about $28,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.